GB/T 16886.11-1997
Replaced
T/SXS 129-2023
Active
Group standards
T/SXS 129-2023 The credit evaluation standards for medical device enterprises' operations
T/SXS 129-2023 The credit evaluation standards for medical device enterprises' operations
Price:
$ 20.00
Basic Information
Standard Code:
T/SXS 129-2023
Standard Type:
Group standards
Standard Status:
Active
is_force_gb:
no
CCS Name:
-
ICS Name:
Integrated medical equipment
Publish Date:
2023-11-30
Implement Date:
2023-11-30
Scope
Main technical content: This document specifies the general requirements, evaluation process, and management and improvement of the operating credit evaluation standards for medical device enterprises. This document is applicable to the operating credit evaluation standards for medical device enterprises.
Development Information
Related Standards
GB/T 16886.3-1997
Replaced
GB/T 16886.3-1997 Biological evaluation of medical devices—Part 3:Tests for genotoxicity, carcinogenicity and reproductive toxicity
GB/T 16886.6-1997
Replaced
GB/T 16886.6-1997 Biological evaluation of medical devices—Part 6:Tests for local effects after implantation
GB/T 16886.1-2001
Replaced
GB/T 16886.1-2001 Biological evaluation of medical devices—Part 1:Evaluation and testing
GB/T 16886.13-2001
Replaced
GB/T 16886.13-2001 Biological evaluation of medical devices—Part 13:Identification and quantification of degradation products from polymeric medical devices
GB/T 16886.7-2001
Replaced